Stifel's Tim Opler shares feedback from SF Healthcare Week and thoughts on biotech's year ahead from a banking perspective
- blonca9
- Jan 22, 2024
- 1 min read
Tim Opler discusses the M&A environment, IPO windown, PIPE and crossover financings, and more.
